155 results
Page 4 of 8
8-K
EX-99.1
zt7iz0xseyic509m50m
25 Mar 21
Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study
5:20pm
8-K
EX-99.1
7jf z8s844fcg
18 Mar 21
Regulation FD Disclosure
4:14pm
8-K
EX-99.1
5qtg0m
17 Mar 21
Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update
4:36pm
424B5
5wzl59nlnjy4los
17 Feb 21
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
6pj2jrh hvivuyr
12 Feb 21
Note Regarding Forward-looking Statements
8:19am
424B5
7vxajcjvry1f90vr1mw
11 Feb 21
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
v4sdgwj wwcme1hj
12 Nov 20
Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates
4:57pm
8-K
EX-10.1
kvd28tx4o 78j1n4oz8a
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
8-K
EX-10.1
tdvyubsrkp67
25 Sep 20
Diffusion Pharmaceuticals Strengthens Management Team with Appointmentof William Elder as General Counsel and Corporate Secretary
4:57pm
8-K
EX-10.2
mna281vp0b5o9ra
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am